Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Concomitant RotaTeq and INFANRIX hexa in healthy infants
2005-003508-12Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2005
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in rotaviral diarrhea comparing RotaTeq + INFANRIX hexa with Placebo + INFANRIX hexa (2 arms). Primary endpoint: PRP seroprotection non-inferiority. Started Dec 2005; status: completed.
02
Drugs
rotavirus vaccine, live, oral, pentavalentpertussis filamentous haemagglutinin
03
Conditions
rotaviral diarrhea
Beyond the preview
Go deeper on 2005-003508-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003508-12.